Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion type Assertion NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_head.
- NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion description "[Because rational treatment strategies require understanding the activation status of the underlying signaling pathway being targeted at the desired stage of disease, the authors examined the activation status of different components of the mTOR pathway in RCC metastases and matched primary tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_provenance.
- NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion evidence source_evidence_literature NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_provenance.
- NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion SIO_000772 20830770 NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_provenance.
- NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion wasDerivedFrom befree-20140225 NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_provenance.
- NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_assertion wasGeneratedBy ECO_0000203 NP570684.RA1jFa3laLt_vlPjOnVCoWd8UPSkj0ac-no9c5Vh4Cqrk130_provenance.